Skip to content

Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer

Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03286920
Enrollment
600
Registered
2017-09-19
Start date
2017-09-20
Completion date
2018-09-30
Last updated
2018-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Keywords

home nutrition, BMI, postoperative, body weight

Brief summary

This clinical trial is designed to be a multi-center prospective observational study which shall compare the effect of different postoperative home nutrition modes on recent nutritional index (weight/BMI) of patients with esophageal cancer and recent outcomes. Different postoperative home nutrition modes adopted in this study includes oral natural diet, oral nutrition supplement and tube feeding.

Detailed description

STUDY BACKGROUND Esophageal cancer is a common cancer in China and due to its influence on diet intake, patients with esophageal cancer are often combined with nutrition deficiency, which causes relatively high nutrition risk to treatment. Studies conducted by Martin et al showed that the degree of body weight loss in patients with malignancy is related to BMI level and prognosis. The patients with severe body weight loss and low BMI have poor prognosis, especially for patients with esophageal cancer. At present, perioperative nutrition support for patients with esophageal cancer has been recognized and has been recommended as routine in 2017 NCCN guideline. How to implement good home nutrition within one month after patient discharge and recover nutrition index as soon as possible has become a focus for esophageal surgeon. Many clinical trials have already investigated enteral nutrition support approach during anti-cancer treatment period in patients with malignancy. However, only a few clinical trials are good designed. Therefore the investigators hope to via this multi-center prospective observational study to provide evidence for this question. OBJECTIVES: 1. To explore the relationship between postoperative home nutrition support treatment approach and nutritional status of patients with esophageal cancer; 2. To explore the relationship between postoperative home nutrition support treatment approach and recent prognosis in patients with esophageal cancer; 3. To promote the standardized application of postoperative home nutrition support treatment for patients with esophageal cancer.\\ OUTLINE: Included patients shall be divided into three groups according to the treatment plan of all centers, including oral natural diet, oral nutrition supplement and tube feeding. As for patients in oral natural diet group, the patients shall receive oral natural diet. As for patients in oral nutrition supplement group, in addition to oral natural die, the participants shall receive oral enteral supplement providing 750-1500kcal/d. As for patients in tube feeding group, in addition to oral natural die, the participants shall receive tube feeding enteral supplement providing 750-1500kcal/d. All the included patients shall be followed up weekly within 1-3 weeks after discharge via telephone, at Day 30 after discharge and at Day 90 after discharge to assess the effectiveness and safety of different home nutrition supplement approaches. PROJECTED ACCRUAL: A total of 600 patients will be accrued for this study.

Interventions

DIETARY_SUPPLEMENTTube feeding nutrition supplement

As for patients in tube feeding group, in addition to oral natural die, the participants shall receive Tube feeding nutrition supplement providing 750-1500kcal/d.

DIETARY_SUPPLEMENTOral nutrition supplement

As for patients in oral nutrition supplement group, in addition to oral natural die, the participants shall receive oral enteral supplement providing 750-1500kcal/d.

Sponsors

Sun Yat-sen University
CollaboratorOTHER
Zhejiang Cancer Hospital
CollaboratorOTHER
Shanghai Chest Hospital
CollaboratorOTHER
China-Japan Friendship Hospital
CollaboratorOTHER
Fudan University
CollaboratorOTHER
Shandong Provincial Hospital
CollaboratorOTHER_GOV
Hebei Medical University Fourth Hospital
CollaboratorOTHER
Anyang Tumor Hospital
CollaboratorOTHER
The First Affiliated Hospital of Anhui Medical University
CollaboratorOTHER
The First Affiliated Hospital of Bengbu Medical University
CollaboratorOTHER
Tongji Hospital
CollaboratorOTHER
Shanxi Province Cancer Hospital
CollaboratorOTHER
The Third Affiliated Hospital of Harbin Medical University
CollaboratorOTHER
Liaoning Cancer Hospital & Institute
CollaboratorOTHER
Wuhan General Hospital of Guangzhou Military Command
CollaboratorOTHER
Second Xiangya Hospital of Central South University
CollaboratorOTHER
The First Hospital of Jilin University
CollaboratorOTHER
Chinese PLA General Hospital
CollaboratorOTHER
Hunan Provincial People's Hospital
CollaboratorOTHER
Fujian Cancer Hospital
CollaboratorOTHER_GOV
Qilu Hospital of Shandong University
CollaboratorOTHER
Union hospital of Fujian Medical University
CollaboratorOTHER
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
CollaboratorOTHER
Peking University Cancer Hospital & Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age below 80 years old; * Esophageal cancer; * Radical surgery; * Normal gastrointestinal function

Exclusion criteria

* Patients with diabetes and poor blood glucose control; * Patients with severe postoperative complications; * Patients who can't tolerate lactose; * Patients who decline inclusion and follow-ups

Design outcomes

Primary

MeasureTime frameDescription
Percentage of 5% body weight loss on Day 30Day 30 after dischargePercentage of 5% body weight loss on Day 30 compared to the body weight at discharge

Secondary

MeasureTime frameDescription
Complications of home enteral nutrition supportDay30Assessment on complications of home enteral nutrition support
Completion ratio of different nutrition support approachesDay 30 after dischargeCompletion ratio of different nutrition support approaches
Quality of life assessment using EORTC QLQ-C30 scale and QLQ-OG25 scaleDay30 and Day 90Assessment on patients' quality of life using EORTC QLQ-C30 scale and QLQ-OG25 scale in different nutrition support approach groups and investigate the relationship between different nutrition support approaches and patients' quality of life
Delay and interruption ratio of adjuvant treatmentDay 30 and Day 90Delay and interruption ratio of adjuvant treatment including whether chemotherapy and radiotherapy can be implemented on time
Re-hospitalization ratioDay 90Re-hospitalization ratio within 90 days after discharge

Countries

China

Contacts

Primary ContactKeneng Chen, M.D.
chenkeneng@bjmu.edu.cn+86 13501085973
Backup ContactLiang Dai, M.D.
dailiangsharp_26@aliyun.com+86 18610065191

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026